This symposium was hosted live on June 10 - 12, 2022.
Come learn about cutting edge oncology nutrition from the leading experts in the field. This bundle of sessions is focused on Gastrointestinal topics.
Management of Gastrointestinal Side Effects of Cancer Treatment
Outline the types of GI side effects seen with cancer therapies highlighting some of the unique features of cancer therapy toxicity. Colitis secondary to immunotherapy would be an example. Discuss the differential diagnosis and the initial steps in working up these side effects since it is important to consider other causes of symptoms in addition to the patients therapy. Discuss treatment and management options and consider when it is important to involve specialists and subspecialists in the patient's care. Introduce potential benefits and limitations of endoscopy in the workup and management of these patients.
CPEU: 1.0
CPE Level: 3
Performance Indicators: 10.2.3, 10.3.9, 8.2.4
Learning Objectives
- Familiarity with common GI side effects of cancer therapy
- Recognizing the second level management options
- Identify when to refer the patient out to a Gastroenterologist
Speaker:
David Richards, MD
The University of Texas MD Anderson Cancer Center
An Oncologist's Perspective: Malnutrition in the Gastrointestinal Cancer Clinic
This session will use 2 cases to highlight the role and practical benefits of malnutrition screening, will review our published data on large scale screening and ongoing work looking at the available evidence for outpatient malnutrition screening, then review common complications of certain anti-cancer therapeutics in GI cancers and finally review novel therapeutics as they relate to malnutrition and cachexia.
CPEU: 1.0
CPE Level: 3
Performance Indicators: 10.1.2, 10.4.4, 8.2.3
Learning Objectives
- Review the evidence and practical aspects of malnutrition screening in ambulatory oncology
- Discuss complications of GI anti-cancer therapies and their effect on optimal nutritional care
- Summarize current novel therapeutics in cancer cachexia
Speaker:
Kunal Kadakia, MD
Levine Cancer Institute, Atrium Health
Prehabilitation for Cancer Patients
This session will discuss the rationale for cancer prehabilitation and provide examples of its execution across various cancer diagnoses.
CPEU: 1.0
CPE Level: 3
Performance Indicators: 10.1.3, 10.3.9, 8.2.3
Learning Objectives
- Describe the rationale for cancer prehabilitation.
- Describe some outcomes of interest for cancer prehabilitation.
- Describe the challenges in cancer prehabilitation research and practice.
Speaker:
Nathan Parker, PhD, MPH
Moffitt Cancer Center
Nutrition Implications of Hyperthermic Intraperitoneal Chemotherapy
This presentation will describe the clinical history, purpose, and administration of hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in various cancers involving the peritoneum. Common nutrition-impact symptoms, appropriate medical nutrition therapy, and metabolic needs will be thoroughly discussed in the preoperative, early postoperative, and long-term postoperative contexts. Participants will learn the importance of incorporating certain non-traditional elements into assessments and recommendations, and have the opportunity to apply these concepts in a case-study format.
CPEU: 1.0
CPE Level: 3
Performance Indicators: 10.5.3, 8.2.1, 8.2.3
Learning Objectives
- Describe HIPEC and how its administration differs from standard chemotherapy;
- Review the disease states commonly treated using HIPEC and the nutrition concerns arising directly from these conditions;
- Explore various approaches for perioperative nutrition management of patients undergoing HIPEC.
Speaker:
Stacy Shawhan, RD, CSO, LD
University of Cincinnati Cancer Center
